Literature DB >> 3043180

c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.

B Lüscher1, R N Eisenman.   

Abstract

The proteins encoded by both viral and cellular forms of the c-myc oncogene have been previously demonstrated to have exceptionally short in vivo half-lives. In this paper we report a comparative study on the parameters affecting turnover of nuclear oncoproteins c-myc, c-myb, and the rapidly metabolized cytoplasmic enzyme ornithine decarboxylase. The degradation of all three proteins required metabolic energy, did not result in production of cleavage intermediates, and did not involve lysosomes or ubiquitin. A five- to eightfold increase in the half-life of c-myc proteins, and a twofold increase in the half-life of c-myb proteins was detected after heat-shock treatment at 46 degrees C. In contrast, heat shock had no effect on the turnover of ornithine decarboxylase. Heat shock also had the effect of increasing the rate of c-myc protein synthesis twofold, whereas c-myb protein synthesis was decreased nearly fourfold. The increased stability and synthesis of c-myc proteins led to an overall increase in the total level of c-myc proteins in response to heat-shock treatment. Furthermore, treatments which reduced c-myc and c-myb protein turnover, such as heat shock and exposure to inhibitors of metabolic energy production, resulted in reduced detergent solubility of both proteins. The recovery from heat shock, as measured by increased turnover and solubility, was energy dependent and considerably more rapid in thermotolerant cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043180      PMCID: PMC363451          DOI: 10.1128/mcb.8.6.2504-2512.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

Review 1.  Polyamines.

Authors:  C W Tabor; H Tabor
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

2.  Immunological analysis of v-myc gene products using antibodies against a myc-specific synthetic peptide.

Authors:  T Patschinsky; G Walter; K Bister
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

3.  Inhibitors of lysosomal function.

Authors:  P O Seglen
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.

Authors:  H Persson; L Hennighausen; R Taub; W DeGrado; P Leder
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

Review 5.  The ubiquitin-mediated proteolytic pathway and mechanisms of energy-dependent intracellular protein degradation.

Authors:  A Ciechanover; D Finley; A Varshavsky
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

6.  Energy requirement for degradation of tumor-associated protein p53.

Authors:  R M Gronostajski; A L Goldberg; A B Pardee
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

7.  Vanadate inhibits the ATP-dependent degradation of proteins in reticulocytes without affecting ubiquitin conjugation.

Authors:  K Tanaka; L Waxman; A L Goldberg
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

8.  Ornithine decarboxylase in mouse kidney. Purification, characterization, and radioimmunological determination of the enzyme protein.

Authors:  V V Isomaa; A E Pajunen; C W Bardin; O A Jänne
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

9.  Identification of nuclear proteins encoded by viral and cellular myc oncogenes.

Authors:  K Alitalo; G Ramsay; J M Bishop; S O Pfeifer; W W Colby; A D Levinson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

10.  The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb.

Authors:  K H Klempnauer; G Ramsay; J M Bishop; M G Moscovici; C Moscovici; J P McGrath; A D Levinson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  52 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Histone sumoylation is associated with transcriptional repression.

Authors:  Yuzuru Shiio; Robert N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

3.  Detection of a Myc-associated protein by chemical cross-linking.

Authors:  D A Gillespie; R N Eisenman
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment.

Authors:  M Stoneley; T Subkhankulova; J P Le Quesne; M J Coldwell; C L Jopling; G J Belsham; A E Willis
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

5.  Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.

Authors:  F A Grässer; P Haiss; S Göttel; N Mueller-Lantzsch
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation.

Authors:  P C Goswami; J L Roti Roti; C R Hunt
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  FH3, a v-myc avian retrovirus with limited transforming ability.

Authors:  C Chen; B J Biegalke; R N Eisenman; M L Linial
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Nucleolar localization of myc transcripts.

Authors:  V C Bond; B Wold
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Authors:  A E Cuddihy; L A Brents; N Aziz; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells.

Authors:  P J Koskinen; L Sistonen; G Evan; R Morimoto; K Alitalo
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.